Our goal is to accelerate scientific discovery to alleviate suffering in neurological diseases.
Our work in recent years highlights that we will not reach this goal alone. Every day, we work with a passionate, innovative, diverse, multidisciplinary team of researchers and physician-scientists at the forefront of biomedical research.
We draw upon our expertise and our innovative collaborations, both within the University of Michigan and worldwide, to accelerate the pace of scientific discovery and support emerging therapies for neurological diseases.
Interdisciplinary collaboration allows us to leverage advanced technologies with our colleagues in genetics, physiology, environmental science, and bioinformatics. This synergy drives breakthroughs in our understanding of brain health and brain diseases. Our partnerships will lead to more personalized and effective treatment options for our patients.
The NeuroNetwork for Emerging Therapies celebrated the generosity of two remarkable donors, Andi and Larry Wolfe, and the installation of Melissa Elafros, M.D., Ph.D., as the inaugural Andrea and Lawrence A. Wolfe Research Professor at a ceremony and reception on the Michigan Medicine campus.
Your help will advance cutting-edge research in brain health, ALS, and the neurologic complications of diabetes and obesity, with the goal of translating knowledge gained in the laboratory into new therapies.
